TATadayuki Ahiko

Tadayuki Ahiko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tadayuki Ahiko has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Measles Outbreak Response Activity in Japan, and a Discussion for a Possible Strategy of Outbreak Response Using Cycle Threshold Values of Real-Time Reverse Transcription PCR for Measles Virus in Measles Elimination Settings

    by Junji Seto, Yoko Aoki, Kenichi Komabayashi, Keiko Yamada, Hitoshi Ishikawa, Tomoo Ichikawa, Tadayuki Ahiko, Katsumi Mizuta

    Measles is a highly contagious, but vaccine-preventable disease caused by the measles virus (MeV). Although the administration of two doses of measles vaccines is the most effective strategy to prevent and eliminate measles, MeV continues to spread worldwide, even in 2022. In measles-eliminated countries, preparedness and response to measles outbreaks originating from imported cases are required to maintain elimination status. Under these circumstances, real-time reverse transcription (RT) PCR for MeV could provide a diagnostic method capable of strengthening the subnational capacity for outbreak responses. Real-time RT-PCR can detect MeV RNA from patients with measles at the initial symptomatic stage, which can enable rapid public health responses aimed at detecting their contacts and common sources of infection. Furthermore, low cycle threshold (Ct) values (i.e., high viral load) of throat swabs indicate high infectiousness in patients with measles. The high basic reproduction number of measles suggests that patients with high infectiousness can easily become super-spreaders. This opinion proposes a possible strategy of rapid and intensive responses to counter measles outbreaks caused by super-spreader candidates showing low Ct values in throat swabs. Our strategy would make it possible to effectively prevent further measles transmission, thereby leading to the early termination of measles outbreaks.


  • Convenient PCR method for variable-number tandem-repeat typing of Mycobacterium tuberculosis clinical isolates

    by Junji Seto, Takayuki Wada, Yu Suzuki, Tatsuya Ikeda, Katsumi Mizuta, Satoshi Mitarai, Tadayuki Ahiko


  • Molecular epidemiology of Coxsackievirus A16 strains isolated from children in Yamagata, Japan between 1988 and 2011

    by Katsumi Mizuta, Chieko Abiko, Yoko Aoki, Tatsuya Ikeda, Yoko Matsuzaki, Seiji Hongo, Tsutomu Itagaki, Noriko Katsushima, Akira Ohmi, Hidekazu Nishimura, et al.

  • Open Access

    Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan

    by Katsumi Mizuta, Mika Saitoh, Miho Kobayashi, Hiroyuki Tsukagoshi, Yoko Aoki, Tatsuya Ikeda, Chieko Abiko, Noriko Katsushima, Tsutomu Itagaki, Masahiro Noda, et al.

    Background: Human parainfluenza virus type 1 (HPIV1) causes various acute respiratory infections (ARI). Hemagglutinin-neuraminidase (HN) glycoprotein of HPIV1 is a major antigen. However, the molecular epidemiology and genetic characteristics of such ARI are not exactly known. Recent studies suggested that a phylogenetic analysis tool, namely the maximum likelihood (ML) method, may be applied to estimate the evolutionary time scale of various viruses. Thus, we conducted detailed genetic analyses including homology analysis, phylogenetic analysis (using both the neighbor joining (NJ) and ML methods), and analysis of the pairwise distances ofHNgene in HPIV1 isolated from patients with ARI in Yamagata prefecture, Japan.Results: A few substitutions of nucleotides in the second binding site ofHNgene were observed among the present isolates. The strains were classified into two major clusters in the phylogenetic tree by the NJ method. Another phylogenetic tree constructed by the ML method showed that the strains diversified in the late 1980s. No positively selected sites were found in the present strains. Moreover, the pairwise distance among the present isolates was relatively short.Conclusions: The evolution ofHNgene in the present HPIV1 isolates was relatively slow. The ML method may be a useful phylogenetic method to estimate the evolutionary time scale of HPIV and other viruses.


  • Stability of the seven hexon hypervariable region sequences of adenovirus types 1–6 isolated in Yamagata, Japan between 1988 and 2007

    by Katsumi Mizuta, Yoko Matsuzaki, Seiji Hongo, Akira Ohmi, Michiko Okamoto, Hidekazu Nishimura, Tsutomu Itagaki, Noriko Katsushima, Hitoshi Oshitani, Akira Suzuki, et al.


    • 1 February 2007
      • Vol. 82  (2) , 119-23

    [Outcomes and problems of DOTS strategy in Japan].

    by Tadayuki Ahiko

    The DOTS strategy promoted by the World Health Organization (WHO) was applied in 183 countries in 2004. The DOTS coverage, defined as the percentage of the population living in areas where health services have adopted DOTS, was 83% globally in 2004, but it was 71% in Japan. The global 2005 targets for tuberculosis (TB) control are to detect at least 70% of infectious TB cases and cure 85% of those cases detected. According to the most recent WHO annual report, the DOTS case detection rate in 2004 was 45% in Japan whereas the global average of it was 53%. The treatment success rate, defined as the percentage of patients (in the 2003 cohort) who are cured or who complete treatment, was 82% globally, but it was 76% in Japan. This relatively low achievement is attributed to the fact that public health centers in some districts operated insufficient monitoring system for evaluation of the treatment outcome by cohort analysis. However, the treatment success rate will not be improved easily because more than half of new TB patients in Japan are old people who tend to have various complications. The Ministry of Health, Labour and Welfare demonstrated the framework of the DOTS Japan version in 2003 to promote the DOTS strategy with collaboration between hospitals, public health centers and welfare organization. The new strategy includes the program for treatment of TB inpatients and the community-based program for outpatients. The latter program called "community DOTS" is classified into three types according to the risk of treatment interruption with an individual patient. The Japanese Society for Tuberculosis should urge the government (at central and regional levels) to enhance political commitment to accelerate activities for TB elimination. It is necessary that the central government build a new public funding system to improve the cure rate under the DOTS Japan version. The local government should strengthen the function of public health centers not only to secure the quality of monitoring system for evaluation of the treatment outcome but to develop human resources who are able to collaborate with public health nurses in promoting the community-based DOTS program.